GWS
PCRX icon

Glassman Wealth Services’s Pacira BioSciences PCRX Stock Holding History

Glassman Wealth Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed – – 2011
2022
Q3 		$0 Buy
+3
New +$167 ﹤0.01% 1900
2021
Q2 		– Sell
-1
Closed – – 1590
2021
Q1 		$0 Buy
+1
New +$71 ﹤0.01% 1575
2018
Q1 		– Sell
-6
Closed – – 874
2017
Q4 		$0 Buy
+6
New +$238 ﹤0.01% 763

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Glassman Wealth Services's PCRX Position: Q4 2022 in Review

Glassman Wealth Services sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 3 shares.

Glassman Wealth Services first reported a position in PCRX in Q4 2017 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • Glassman Wealth Services reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 3 Pacira BioSciences shares in Q4 2022.
  • Glassman Wealth Services first reported a position in Pacira BioSciences in Q4 2017 and held it in 3 quarters.
  • Glassman Wealth Services's Pacira BioSciences position peaked at $0 in Q3 2022.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Glassman Wealth Services's 13F filing for Q4 2022, filed 6 Feb 2023.